Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    90.00 (2.45%)
Bid:
3,744.00
Ask:
3,748.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Director/PDMR Shareholding

2 May 2025 15:47

RNS Number : 3041H
4imprint Group PLC
02 May 2025
 

2 May 2025

 

4imprint Group plc (the "Company")

 

Director/PDMR Incentive Plan Awards

 

 

The Company received notification on 30 April 2025 from Michelle Brukwicki, informing it that her award granted on 9 December 2024 had vested in respect of 3,667 ordinary shares of 38 6/13 pence each in the Company ("Ordinary Shares"), pursuant to the 4imprint Group plc Long Term Incentive Plan (the "Plan"). The award was net settled in respect of 1,174 Ordinary Shares withheld to cover statutory tax liabilities, and the Company also received notification that, on 2 May 2025, Michelle sold a further 550 Ordinary Shares at a price of £31.20 per share in order to meet the remaining tax liabilities arising on the vesting of the share awards. 

 

These transactions, in accordance with the rules of the Plan, represent the vesting of buyout awards granted to Michelle on her joining the Company. As a result, the total interests of Michelle Brukwicki in the Company are 1,943 Ordinary Shares, representing 0.01% of the Company's issued share capital.

 

 

Emma Taylor

Company Secretary

4imprint Group plc

Tel: + 44 (0) 20 3709 9680

Email: hq@4imprint.co.uk

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulations, provides further detail in respect of the transaction as described above. 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Michelle Brukwicki

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

4imprint Group plc

b.

LEI

213800G95T751RN2CT94

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the Financial instrument, type of instrument:

Identification code:

Ordinary shares of 38 6/13 pence

 

 

 

GB0006640972

b.

Nature of the transaction

Vesting of share awards under the 4imprint Long Term Incentive Plan

c.

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

3,667

d.

Aggregated information

 

·Aggregated volume

 

·Price

 

 

 

3,667

 

Nil

e.

Date of the transaction

30 April 2025

f.

Place of the transaction

 

Outside of a trading venue

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the Financial instrument, type of instrument:

Identification code:

Ordinary shares of 38 6/13 pence

 

 

 

GB0006640972

b.

Nature of the transaction

Subsequent net settlement and sale of shares to meet tax liabilities arising on vesting of conditional share awards

c.

Price(s) and volume(s)

Price(s)

Volume(s)

£34.00

1,174

(net settlement)

£31.20

550

(sale)

d.

Aggregated information

 

·Aggregated volume

 

·Price

 

 

 

1,724

 

£33.11

e.

Date of the transaction

2 May 2025

f.

Place of the transaction

London Stock Exchange

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFSSEEIFIIE
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.